Literature DB >> 6687221

Correlation of the structure of amino-substituted anthraquinones to cytotoxicity in cultured Chinese hamster cells.

B F Kimler, C C Cheng, R E Barnes, M L Barnes.   

Abstract

A number of substituted anthraquinones (SAQs) are currently being tested as cancer chemotherapeutic agents because of their structural similarity to Adriamycin (ADR) and other DNA-intercalating antibiotics. In this study, the effect of SAQs on the induction of cytotoxicity of asynchronous Chinese hamster cells in culture was studied and compared to those produced by ADR and dihydroxyanthraquinone (DHAQ), a SAQ previously shown to be more effective than ADR. SAQs produced cytotoxicity that was dependent upon the concentration and duration of drug exposure. A correlation was noted between the activity of a compound (the concentration required to produce a certain level of cell kill) and the presence of a particular triangular arrangement of one nitrogen atom and two oxygen atoms. There was also a correlation between chemical structure and antitumor activity in the murine P388 leukemia model system. This correlation between chemical structure and biological activity may aid in the development of new SAQs with greater potential as cancer chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687221     DOI: 10.1007/bf00208892

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  14 in total

1.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

2.  Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracycline antibiotics.

Authors:  C C Cheng; G Zbinden; R K Zee-Cheng
Journal:  J Pharm Sci       Date:  1979-03       Impact factor: 3.534

3.  Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.

Authors:  D D Von Hoff; E Pollard; J Kuhn; E Murray; C A Coltman
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

4.  Effect of dihydroxyanthraquinone (DHAQ) and radiation on the survival of cultured Chinese hamster ovary cells.

Authors:  B F Kimler
Journal:  Radiat Res       Date:  1983-02       Impact factor: 2.841

5.  Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.

Authors:  R E Wallace; K C Murdock; R B Angier; F E Durr
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

6.  Experimental antitumor activity of aminoanthraquinones.

Authors:  R K Johnson; R K Zee-Cheng; W W Lee; E M Acton; D W Henry; C C Cheng
Journal:  Cancer Treat Rep       Date:  1979-03

7.  Comparison of the effects of dihydroxyanthraquinone and adriamycin on the survival of cultured Chinese hamster cells.

Authors:  B F Kimler; C C Cheng
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

8.  Effect of dihydroxyanthraquinone and radiation on G2 progression.

Authors:  B F Kimler
Journal:  Cancer Res       Date:  1980-01       Impact factor: 12.701

9.  Antiproliferative activity of doxorubicin and aminoanthraquinone derivatives on Chinese hamster ovary cells.

Authors:  E M Uyeki; A Nishio; P J Wittek; C C Cheng
Journal:  J Pharm Sci       Date:  1981-09       Impact factor: 3.534

10.  Sister-chromatid exchange and chromosomal aberrations by DHAQ and related anthraquinone derivatives in Chinese hamster ovary cells.

Authors:  A Nishio; F DeFeo; C C Cheng; E M Uyeki
Journal:  Mutat Res       Date:  1982-03       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.